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The immune response to a specific antigen can frequently be shown to be dominated 
by antibody molecules bearing a particular idiotype (IdX) 1 (1). Although an idiotype 
is  defined  as  a  variable-region  marker and  is  usually  associated  with  a  particular 
antigen specificity, several groups (2-13) have shown that individual idiotypic deter- 
minants can sometimes be found on antibodies of distinct speeificities. This finding, 
together with the evidence demonstrating IdX-specific helper (14, 15) and suppressor 
T  cells  (16,  17),  is  in  accord  with Jerne's  network  theory  (18)  and  suggests  that 
idiotypic recognition per se plays a pivotal role in regulating IdX expression. Never- 
theless, little is known about the control of IdX expression after antigen injection and 
in only a few cases has it been shown that idiotypic modulation actually occurs during 
the specific antibody response (19-2 I). 
In every mouse strain examined, most antibody produced against the small protein 
antigen, hen eggwhite lysozyme (HEL), appears to be specific for a restricted portion 
of the HEL molecule and bears a  predominant  idiotype (IdX-HEL)  (22,  23).  IdX- 
HEL can  be defined  by sera raised  in  guinea  pigs or rabbits against  conventional 
anti-HEL antibody;  using monoclonal  reagents, we recently demonstrated  that  the 
presence of IdX-HEL can be dissociated from the major epitypic specificity of anti- 
HEL activity (8).  In this paper, we present evidence that IdX-HEL-bearing antibody 
becomes selected for during the maturation of the anti-HEL response. Thus, epitope- 
specific and idiotype-specific recognition processes are coordinated in the regulation 
of the response to HEL. 
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Materials  and  Methods 
Animals and Cell Lines. 6-10-wk-old B10.A and A/J mice were obtained from The Jackson 
Laboratory, Bar Harbor, Maine. (BALB/c X B10.A)Fx and (BALB/c X A/J)F1 mice were bred 
in our colony. The cell lines P3 ×  63Ag8 (P3) (24), S 194/5.XXO.BU. 1 (S 194/5)  (25), and Sp2/ 
O-Agl4  (Sp2/0)  (26)  were  obtained  from  The  Salk Institute, La Jolla, Calif.  The  P3  line 
secretes IgG1 MOPC21  immunoglobulin; the S19.4/5 and Sp2/O lines are variants that have 
lost the ability to synthesize immunoglobulin. The cell lines were maintained in RPMI  1640 
(Grand Island Biological Co., Grand Island, N.  Y.)  containing  15%  fetal calf serum  (FCS) 
(Microbiological Associates, Walkersville, Md.), 2 mM L-glutamine, 1 mM sodium pyruvate, 
100 U/ml penicillin, and  100/~g/ml streptomycin (all from Grand Island Biological Co.). 
Cell Fusion. Mice were immunized intraperitoneally, subcutaneously, and  in each footpad 
with 100/zg, 25/tg, and 25/~g, respectively, of HEL (Societa Prodotti Antibiotici, Milan, Italy), 
emulsified in complete Freund's adjuvant  (CFA) (Difco Laboratories, Detroit, Mich.). For a 
primary  response,  cell  suspensions  were  prepared  from  combined  parathymic,  periaortic, 
inguinal,  and  popliteal lymph  nodes,  removed  9  d  after  immunization.  For  a  secondary 
response, the primed mice were boosted intraperitoneally, subcutaneously, and in the footpad 
with 100 p,g, 25/~g, and 25/~g, respectively, of HEL in incomplete Freund's adjuvant 28 d after 
the initial immunization.  3-5  d  later, cell suspensions were pret~ared from  the spleens and 
lymph nodes. The lymphoid cells (1 ×  107) were fused with 1 ×  10~ myeloma cells according to 
the method of Gefter et al. (27) using 35% polyethylene glycol 1540 (J. T. Baker Chemical Co., 
Phillipsburg, N. J.). After fusion, the cultures were gradually selected in microtiter plates (Flow 
Laboratories,  Hamden,  Conn.)  over  a  2-wk  period  in  medium  containing  hypoxanthine, 
aminopterin, and thymidine (HAT medium) and then incubated an additional 2 wk in HAT 
medium without aminopterin before transfer to RPMI 1640-15% FCS. Under these conditions, 
-10% of the wells showed cell growth 2-4 wk after fusion, and of these, 30-50% contained anti- 
HEL antibody. 
Screening the Hybridoma Cultures for Anti-HEL Antibody. Cells that grew in HAT medium were 
assayed  for  secretion  of anti-HEL  antibody  using  anti-mouse  immunoglobulin  facilitated 
hemagglutination of HEL-coupled sheep erythrocytes (RBC).  HEL was coupled to RBC by 
the mannitol-carbodiimide method previously described by our laboratory (28).  The test was 
performed  in  U-bottomed  mierotiter  plates  (Cooke  Laboratory  Products,  Div.  Dynatech 
Laboratories, Inc., Alexandria, Va.) using 25/~1 of culture supernate and 25/~1 of 0.1%  HEL- 
RBC  suspended  in  a  1:75  dilution of guinea  pig anti-mouse immunogiobulin serum.  This 
technique is capable of detecting <1 ng of anti-HEL antibody. 
Cloning and In Vivo Propagatwn of Anti-HEL Hybridomas. Hybridoma cultures that secreted anti- 
HEL antibody were cloned by limiting dilution. The cloning was ~performed in microtiter plates 
(Flow Laboratories) using normal BALB/c spleen cells (3 ×  10  cells/well) as a  feeder layer. 
The efficiency of cloning was confirmed by isoelectric focusing (IEF). For ascites production, 1 
×  10°-5 ×  l0  s cloned cells were injected intraperitoneally into F1 (BALB/c ×  B10.A; BALB/c 
×  A/J) mice that had been injected  1-2 wk earlier with 0.5 ml Pristane (2,6,10,14-tetrame- 
thylpentadecane)  (Aldrich Chemical Co., Milwaukee, Wise.). Ascites fluid usually developed 
after 2 wk and yielded on the average 5 mg/ml specific antibody. 
Nomenclature  for Anti-HEL Itybridomas. The nomenclature adopted for the various hybridomas 
is as follows: the first number represents the myeloma cell parent: a  "2" signifies the Sp2/0 
myeloma, a "3" signifies the P3 myeloma, and a "5" indicates the S194/5 myeloma. The next 
two numbers represent when the lymphoid cells were obtained from the immunized donor, e.g., 
"19"  indicates that  fusion was performed on  a  primary response day 9  sample (an  "early" 
hybridoma) and "25" indicates that fusion was performed on day 5 of the secondary response 
(a "late" hybridoma). The final three symbols identify the particular eel] line. The mouse strain 
used as the source of lymphoid cells has not been denoted because we have not observed any 
qualitative differences in the pattern of idiotype development in A/J and B10.A mice to HEL. 
Preparation of Anti-Idiotype Antisera. Anti-HEL  antibody  from  individual B10.A  mice  was 
obtained from ascites fluids that were raised by the procedure of Tung and Nisonoff (29) using 
multiple injections of HEL-CFA at a  1:9 ratio. The immunoglobin fraction of the ascites was 
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coupled with HEL, and the bound antibody was eluted with 0.2 M  glycine sulfate buffer, pH 
2.3, neutralized with 1.0 M  Tris buffer, and dialyzed extensively against physiological saline. 
Anti-idiotype antisera were raised in guinea pigs and rabbits by priming with 200 #g of the 
isolated anti-HEL antibody in CFA, followed by boosting 4 wk later with 200 #g in saline. 
Each anti-idiotype antiserum was passed over an  HEL immunoadsorbent and then isotypic 
and allotypic specificities were removed by repeated absorption over an Affigei-10 column to 
which normal B 10.A immunoglohulin had been conjugated. 
Anti-ldiotype Absorption oflEF Patterns. IEF of anti-HEL ascites fluids was performed in 5% 
polyacrylamide gels as described by Awdeh et al. (30) as modified in our laboratory by Ceeka 
et al. (31).  The focused gels were exposed to 125I-HEL at 37°C for 15 min. The gels were then 
incubated in  18%  (wt:vol) sodium sulfate to precipitate the immunoglobulin, fixed in 0.2% 
(vol:vol) glutaraldehyde, washed, dried, and exposed on  Kodak NS-2T x-ray film (Eastman 
Kodak Co., Rochester, N. Y.). 
For absorption of IEF patterns, various amounts of anti-idiotype antisera were mixed with 
a  constant amount of the ascites fluid to be tested and the mixtures were then incubated at 
37°C for 30 min and at 4°C overnight. The entire contents were plated on IEF polyacrylamide 
gels next to control mixtures containing an equivalent amount of ascites fluid that had been 
incubated with saline. The idiotype-anti-idiotype  complexes that form during the incubation 
period are apparently too large to enter the gel, leading to the elimination of reactive bands. 
Anti-ldiotype Inhibition of Antigen Binding. For inhibition of antigen binding by anti-idiot~e, 
20-#1 samples of anti-HEL ascites fluid or serum at a dilution that binds 30-80% of 10 ng  I- 
HEL were incubated with varying amounts of anti-idiotype antiserum at 37°C for 60 min. To 
these mixtures was added 100 #1 of 100 ng/mi 125I-HEL and incubation was continued at 37°C 
for  30  rain  and  at  4°C  overnight.  All dilutions  were  made  in  phosphate-buffered  saline 
containing  20%  normal  rabbit  serum.  The  amount  of bound  antigen  was  determined  as 
described previously (23). 
Anti-Idiotype Inhibition of Plaque-forming Cells (PFC).  Anti-HEL IgG plaque  inhibition was 
performed  in  Cunningham  slide chambers  (32)  using  an  anti-idiotype antiserum  that  was 
absorbed extensively with mouse RBC and HEL-coupled goat RBC before use. Immunized cell 
populations were adjusted to yield -200  PFC/slide. Goat  RBC and lysozyme-coupled goat 
RBC were used at a  1%  final concentration. Various dilutions of anti-idiotype were added to 
the cells, together with guinea pig complement and guinea pig anti-mouse immunoglobulin 
facilitating serum, to a total volume of 200 #1. The mixtures were incubated in slide chambers 
for 2 h at 37°C and the PFC were enumerated immediately. 
Absorption of Anti-Idiotype with Hybridoma Antibodies. Normal A/J immunoglobulin eluted from 
a protein A column or hybridoma antibodies eluted from an HEL column were trace-labeled 
with  t25I and  coupled  to  Affigel-10 beads.  The  anti-idiotype antiserum  (250  #1)  was  then 
incubated with  50 #g insolubilized protein at  4°C  overnight with continuous rocking. The 
mixtures were centrifuged and the supernates were tested for inhibition of I~I-HEL binding to 
an HEL-induced A/J ascites fluid. 
Results 
Derivation and Analysis of Anti-HEL Hybridomas.  A  preliminary hybridization experi- 
ment with lymphocytes from singly injected mice had yielded hybrid cell lines that in 
every case failed to display the predominant anti-HEL idiotype. To explore the reason 
for  this  apparent  anomaly,  several  hybridizations  were  performed  by  fusing  P3, 
SP2/O,  and  S194/5  myeloma  cells  with  both  primary  and  secondary  response 
lymphocytes. Lymphoid cells for the production of"early" hybridomas were obtained 
from BI0.A or A/J  mice 9  d  after priming, i.e., at the peak of the primary anti-HEL 
response. "Late" hybridomas were derived using cells from primed and boosted mice 
undergoing a  secondary response to HEL on day 3 or 5 after boosting. Over 40 anti- 
HEL  hybridomas were  established by  limiting dilution cloning and  representative 
lines were grown as ascites fluids in syngeneic mice. 
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was determined by a solid-phase radioimmunoassay using rabbit anti-subclass antisera 
(kindly provided by Dr. J. Teale and Dr. N. Klinman, Scripps Clinic and Research 
Foundation,  La Jolla, Calif.)  and  125I-goat anti-rabbit  IgG to assess  binding of the 
hybridoma culture supernates  to  HEL.  It  was  found that  all  but  two of the  lines 
secreted IgG1-K antibody; one line (525.6D7) produced IgG2b antibody, whereas the 
other (525.5E5) produced IgMr antibody (data not shown). These results agree with 
analyses of both  primary and  secondary response sera  from HEL-immune mice in 
which  almost  all  of the  antibody  appears  to  be  IgGlr  and  only  very little  IgM 
antibody is detected (A. Furman, unpublished data). 
Idiotypic Characterization  of  Hybridoma Antibodies. Our laboratory has previously shown 
(15, 16) that anti-idiotypic antisera raised against restricted anti-HEL serum antibody 
populations recognize almost all anti-HEL activity produced in vivo by several strains 
of primed and boosted mice. It was therefore of interest to determine whether such 
anti-idiotypic antisera would react with the hybridoma antibodies. 
Absorption of antibody IEF patterns by anti-idiotype was used for initial idiotypic 
screening  (23).  In  this  assay,  removal  of idiotype-positive bands  by  formation  of 
idiotype-anti-idiotype complexes, which  are  apparently  too  large  to  enter the  gel, 
results in the elimination of reactive bands  from the IEF pattern.  An  anti-idiotype 
antiserum raised against isolated anti-HEL antibody from a hyperimmunized B10.A 
mouse was mixed with ascitic fluids containing monoclonal antibody. The mixtures 
were plated on IEF gels next to ascitic fluids incubated with saline as a control. This 
treatment  removes the entire anti-HEL banding  pattern  from antibodies  of HEL- 
hyperimmunized mice, but has little effect on murine anti-human lysozyme (HUL) 
antibody, which is only poorly cross-reactive with HEL (23). Similarly, representative 
late hybridoma antibodies derived from primed and boosted mice are, in every case, 
totally reactive with the anti-idiotype antiserum  (Fig.  1). This finding was obtained 
even  with  monoclonal  antibodies  of different  fine specificities, e.g.,  525.6C10  and 
Fxo.  1.  Reaction  of anti-idiotype with late hybridoma antibodies. Hybridoma anti-HEL ascitic 
fluids were incubated with saline (a, c, e, g, i, k, m, o) or anti-idiotype Co, d, f, h,j, 1, n, p) at a 1:9 
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Fie. 2.  Failure of anti-idiotype to react with early hybridoma antibodies. Hybridoma anti-HEL 
ascitic fluids were incubated with saline (a, c, e, g, i, k, m) or anti-idiotype (b, d, f, h, j, 1, n) at a 
1:9 ratio before focusing. The gels were incubated with ~zSI-HEL. 
225.2D1, 2 and peptide specificities, e.g., 525.5E4 and 525.6D7  (8). Thus, as shown in 
ref. 8, antibodies specific for distinct epitopes on the HEL molecule are reactive with 
anti-idiotype antibody. 
Early hybridoma antibodies  derived from mice undergoing a  primary response to 
HEL were  tested  in  a  similar  manner  for idiotypy.  In this  ease,  however, we found 
that  the IEF banding patterns  of early monoelonal  antibodies  obtained  from either 
A/J or B 10.A mice were unaffected by anti-idiotype treatment  (Fig. 2). 
This intriguing result indicated a  difference between the idiotypy of early and late 
hybridoma antibodies.  This was confirmed by using the  fact that anti-idiotype,  but 
not polyvalent anti-immunoglobulin  antiserum,  interferes  with  the binding of anti- 
HEL antibody to 12~I-HEL in a standard Farr-type assay. Once again, it was observed 
that anti-idiotype inhibits the binding of late hybridoma antibodies  to HEL but has 
little  effect  on  early  antibodies  (Fig.  3).  This  experiment  further  shows  that  anti- 
idiotype  competes  equally  well  with  the  binding  of HEL  to  antibodies  of distinct 
peptide specificity. 
Individual Mice Express the Predominant ldiotype Only after Prolonged  Exposure to HEL.  The 
findings  with  hybridoma  antibodies  indicated  that  the  predominant  idiotypic 
marker(s)  becomes expressed only after maturation  of the anti-HEL response.  It was 
therefore  of interest  to  determine  whether  parallel  results  would  be  obtained  with 
serum anti-HEL antibody produced in vivo by individual mice. To test this possibility, 
anti-idiotype was used to inhibit PFC formation by parathymic lymph node cells that 
were  obtained  from  BI0.A  mice  undergoing  primary  and  secondary  responses  to 
HEL.  As seen  in  Fig.  4, secondary,  but  not  primary  PFC  were  totally  inhibited  by 
anti-idiotype  antiserum.  Anti-HUL  PFC  from  HUL-immunized  B10.A  mice  were 
almost unaffected by this treatment. 
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Fro.  3.  Anti-idiotype inhibition of HEL  binding to  late but  not early hybridoma antibodies. 
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FIG. 4.  Anti-idiotype inhibition of secondary but not primary response anti-HEL PFC formation, 
Effects of increasing amounts of anti-idiotype on primary day 9 (O) and secondary day 6 (0) PFC 
formation by parathymic lymph nodes from HEL- (  ) or HUL- (---) immunized B10.A mice. 
These results were confirmed by following the anti-HEL sera of individual mice for 
the appearance of the anti-HEL isotypic marker. B 10.A and A/J mice were primed 
with HEL and bled 9 d  later. The mice were rested for 3 wk, boosted, and bled 5 d 
after secondary immunization. These primary and secondary response sera were then 
tested for anti-idiotype-mediated inhibition of HEL binding.  It was  found that, in 
every animal, secondary response serum antibody was almost completely inhibited by 
anti-idiotype, whereas primary response antibody was  not  inhibited  (Fig.  5).  Anti- 
idiotype had no effect on the binding of a25I-HUL to anti-HUL antibody. Experiments 
designed to assess peptide specificity in a solid-phase radioimmunoassay have shown 
approximately  the  same  relative  proportions  of antibody  reactive with  the  NH~- 
terminal-COOH-terminal (N-C) peptide (amino acids I- 17; cys 6-cys 127;  120-129) 
and the mixed-disulfide LII peptide (amino acids  13-105) of HEL in both primary 
and secondary response sera (data not shown). Thus, a  predominant marker(s) that 
is  unrelated  to  epitope  specificity becomes  selected  for  during  the  course  of the 
immune response of HEL. 
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FIc.  5.  Serum anti-HEL antibody in individual mice displays the IdX-HEL specificity only late 
in the immune response. Effects of increasing amounts of anti-idiotype on B 10.A and A/J primary 
day 9 and secondary day 5 serum anti-HEL binding to l~I-HEL.  Primary day 9 anti-HEL, (O), 
secondary day 5 anti-HEL, (O). The effect of anti-idiotype on the binding of anti-HUL to I~I-HUL 
is also shown (&) in B10.A #8, immunized with both antigens. 
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FxG.  6.  Attempted absorption of the anti-IdX activity from guinea pig antiserum raised against 
serum idiotype was performed with 50 ~g of three different affinity-purified monoclonal antibodies, 
or normal immunoglobulin 5E4 late, (ZX); AG5, (0); and AD-2 early, (A); unabsorbed, (Q); normal 
mouse immunoglobulin absorbed, (O). 
Idiotypic Determinant (IdX-HEL).  Because the anti-idiotypic antisera used in this study 
were  raised  against  a  heterogenous antibody population obtained  from  a  hyperim- 
munized mouse, it is unclear whether these reagents were recognizing several distinct 
idiotypes or a major idiotypic determinant, IdX-HEL, shared by almost all secondary 
anti-HEL antibody. To answer this question, anti-idiotype was absorbed with each of 
several hybridoma antibodies and subsequently tested for residual activity against a 708  LATE APPEARANCE OF MAJOR IDIOTYPE IN ANTI-LYSOZYMES 
heterogenous,  HEL-induced  antibody  population.  We  reasoned  that  if the  anti- 
idiotype were recognizing many different idiotypic markers, absorption with mono- 
clonal antibody would have little or no effect on its ability to react with heterogenous 
antibody.  However, if one set of common markers was being recognized primarily, 
this absorption should completely abolish reactivity. An anti-idiotype antiserum was 
absorbed with  50 #g purified normal  mouse immunoglobin  or various hybridoma 
antibodies coupled to Affigel beads. The absorbed antiserum was  then assessed  for 
inhibition of HEL binding to a  heterogenous anti-HEL ascites  fluid.  It was  found 
that absorption with normal immunoglobin or early hybridoma antibodies had little 
effect  on  anti-idiotype  activity  ~ompared  with  an  unabsorbed  control,  whereas 
absorption with a single late hybridoma antibody completely abolished activity (Fig. 
6). Absorption with the immunoglobulin fractions of two other late hybridoma ascitic 
fluids also removed all  of the  activity from this  anti-idiotype antiserum  (data  not 
shown).  Thus,  the  anti-idiotype antisera appear to recognize an  IdX-HEL marker 
common to all late hybridoma and serum anti-HEL but absent on early hybridoma 
and serum antibody. 
Discussion 
We  have  used  both  hybridoma and  serum  antibodies  and  PFC  to  analyze  the 
changing idiotypic nature of the antibody produced in response to a  small protein 
antigen,  HEL.  Results  with  the  two  mouse  strains  studied  here  indicate  that  a 
predominant idiotypic marker, IdX-HEL, is found on almost all secondary response 
anti-HEL antibody in each mouse (Fig. 5). Yet IdX-HEL is not expressed on primary 
response antibody, IdX-HEL gaining predominance only after development of the 
anti-HEL response. This is indicative of  a selective pressure related to the maturational 
stage of the response but not directly related to antigen specificity. 
Almost  all  secondary response  anti-HEL  antibody  derived  from  hybridomas or 
produced in individual animals expressed the predominant IdX-HEL marker. Simi- 
larly, secondary PFC were totally inhibited by anti-idiotype antisera, whereas primary 
PFC were not affected. The absorption studies with monoclonal antibodies confirm 
the previous conclusion (23)  that IdX-HEL is a  determinant shared by all idiotype- 
positive serum antibody rather than a number of different idiotypic markers carried 
by distinct  B cell populations. This interpretation is supported by the finding that 
anti-idiotypic antisera raised against  several single anti-HEL hybridomas recognize 
>90% of the anti-HEL antibody in the sera of primed and boosted mice (33). 
In agreement with our previous results using anti-idiotypic reagents raised against 
hybridoma  antibodies  (8),  IdX-HEL  was  found  on  late  hybridoma  antibodies  of 
distinct  epitope specificity.  Experiments  using serum  antibody similarly  indicated 
that  idiotype was unrelated to specificity. Nevertheless, anti-idiotypic antibody was 
still  able  to inhibit  the  binding  to  HEL.  Probably IdX-HEL is  a  variable-region 
framework determinant close to the antigen-combining site for the bulky macromo- 
lecular  ligand.  Although  most  studies  involving  myeloma  proteins  and  antibody 
responses in  inbred mice have indicated that  idiotypy is closely related to antigen 
specificity, our findings, like those of Oudin and Michel (2), Cazenave (3), and others 
(4-7,  9-13),  clearly show that  idiotypy can  in  some  instances  be dissociated  from 
specificity. In particular, Eichmann et al.  (4) have shown that the A5A idiotype can 
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carbohydrate. Also working with mice, Enghofer et al.  (6)  have shown that immu- 
noglobulins with specifieities for different carbohydrates can share idiotypy. More 
recently, experiments exhibiting dissociation of idiotype from antigen specificity have 
been reported for the cross-reactive idiotype associated with anti-azophenylarsonate 
binding (11),  the 460  idiotype associated with anti-trinitrophenyl binding (12),  the 
GTGL idiotype (9), the T15 idiotype (13), and idiotype associated with anti-myoglo- 
bin antibodies (10).  Possibly all "predominant IdX idiotype" systems involve regu- 
latory idiotopes that are not confined to antibodies of a single specificity. Of course, 
idiotopes unique to single hybridomas or subgroups of hybridomas can also be found. 
Because IdX-HEL is not associated with epitope specificity, antigen-specific cells 
evidently do not play a direct role in the later predominance of this idiotype. Instead, 
idiotype selection presumably mediated by idiotype-specific T  helper cells (IdXTh) 
can be invoked as the major causative agent for this selection; recent evidence has 
shown that such IdXTh cells are needed together with antigen-specific T  helper cells 
(AgTh)  for the optimal induction of an in vitro anti-HEL antibody response  (15). 
Others have similarly demonstrated the importance of idiotype- (14), allotype- (34), 
and isotype-specific (35) helper T  cells in other antigen systems. 
Perhaps most interesting and in marked contrast to secondary response anti-HEL 
activity, the IdX-HEL marker was not detectable on antibody obtained shortly after 
HEL immunization or on the early hybridomas. It is not clear at present whether an 
early, alternative IdX exists or whether there is simply a broad diversity ofclonotypes 
with individual idiotypic markers.  Preliminary evidence using anti-hybridoma idi- 
otypic antisera suggests that  some early hybridoma antibodies share one or more 
determinants with late hybridomas. Idiotope analysis is underway in this and other 
laboratories (36, 37) to reveal the complexity of the anti-HEL idiotypic system. 
The interactions that lead to the predominance of a singular idiotypic motif need 
to be defined clearly. One of the ambiguous areas in the study of idiotypic systems is 
the kinetics of expression of the predominant idiotype. The impression can be gleaned 
from several systems (e.g.,  19-21)  that IdX is expressed early on a majority of antibody 
molecules,  and  subsequently  its  predominance  abates,  owing  to  replacement  or 
conjunction with other molecular species.  In  contrast, the anti-lysozyme system is 
characterized by a clear-cut lag in IdX appearance; a  detailed examination of IdX- 
HEL expression will be published elsewhere. 
It is possible that in certain strains, whose idiotype-specific T cells have been primed 
by self-constituents, IdX  predominance is maintained by continual environmental 
antigenic challenge. This would establish a regulatory circuitry that would be engaged 
after antigen administration to promote the early appearance of IdX and its subse- 
quent suppression. It is interesting that in the anti-HEL response, the forces influenc- 
ing IdX-HEL predominance are especially powerful, because once established, IdX- 
HEL seems to maintain dominance. 
In summary, we conclude that two different selective pressures act independently 
in determining the nature of the antibody response to HEL. Because it has been found 
that AgTh cells of H-2  a mice primarily recognize a determinant(s) in the Ln region of 
HEL (38),  under the influence of the H-2 complex, we would like to attribute the 
prevalent epitypic specificity of the B cells, i.e., N-C specificity, to antigen-bridging 
constraints in T-B cell collaboration, which require the presentation of an opposed 
epitope to the B cell. If antigen-specific selection occurs early, with little involvement 710  LATE APPEARANCE OF MAJOR IDIOTYPE IN ANTI-LYSOZYMES 
of IdXTh, then antibody produced a short time after HEL immunization would bear 
a heterogenous array of idiotypic markers. At this point, those N-C-specific and rare 
Ln-specific B cell clones displaying IdX-HEL would be selected by IdXTh cells for 
further expansion. Thus, a combination of potent idiotypic selection by IdXTh cells 
and epitope selection by AgTh cells would explain the common finding of  convergence 
between  idiotypy and  antigen  specificity. We have not  as yet detected IdX-HEL- 
displaying antibody among early populations, possibly because of the relatively small 
sample size of our early hybridomas and the inability of our serum analyses to detect 
minor proportions of IdX-HEL-positive antibody. 
It remains a major puzzle why the IdX-HEL should be so prevalent and dominant 
not only in every strain of mouse but also in deer mice and rabbits (23; C. Benjamin, 
unpublished observations). Further work is also needed to determine how the IdXTh 
cells become activated, although we have discussed several possibilities elsewhere (39). 
Summary 
A  panel of hybridoma antibodies obtained from lymphoid cells that  were fused 
during  a  primary  response  ("early") or  a  secondary response  ("late")  gave results 
concordant with analysis of conventional, in vivo-produced anti-lysozyme idiotypes: 
early antibodies did not display the predominant anti-hen eggwhite lysozyme idiotype 
(IdX-HEL), whereas late antibodies all displayed IdX-HEL. Furthermore, individual 
late hybridomas could each remove the entire anti-IdX-HEL activity by absorption, 
whereas early hybridomas could not. The epitope specificities of the hybrodomas in 
both the early and  late populations were heterogenous. We conclude that  epitypic 
specificity  in  the  response  to  HEL  is  determined  independently  from  idiotypic 
specificity and that the predominant idiotype is selected for during the maturation of 
the anti-lysozyme response. 
Received  for publication 5 May 1981. 
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